Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00765817

Public ClinicalTrials.gov record NCT00765817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the efficacy and safety of exenatide versus placebo in adults whose diabetes is not fully controlled by insulin glargine with or without metformin and/or pioglitazone.

Study identification

NCT ID
NCT00765817
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
261 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2008 (Type not available)
Primary completion
Jan 2010 (Actual)
Completion
Jan 2010 (Actual)
Last update posted
Oct 24, 2016

2008 – 2010

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
40
Facility City State ZIP Site status
Research Site Peoria Arizona — —
Research Site Phoenix Arizona — —
Research Site Buena Park California — —
Research Site Concord California — —
Research Site Fresno California — —
Research Site Greenbrae California — —
Research Site La Mesa California — —
Research Site Lancaster California — —
Research Site Northridge California — —
Research Site Palm Springs California — —
Research Site Salinas California — —
Research Site Hollywood Florida — —
Research Site Jacksonville Florida — —
Research Site Atlanta Georgia — —
Research Site Honolulu Hawaii — —
Research Site Idaho Falls Idaho — —
Research Site Des Moines Iowa — —
Research Site Wichita Kansas — —
Research Site Baton Rouge Louisiana — —
Research Site Lafayette Louisiana — —
Research Site Matairie Louisiana — —
Research Site Boston Massachusetts — —
Research Site Minneapolis Minnesota — —
Research Site Chesterfield Missouri — —
Research Site St Louis Missouri — —
Research Site Omaha Nebraska — —
Research Site Las Vegas Nevada — —
Research Site Berkeley Heights New Jersey — —
Research SIte Teaneck New Jersey — —
Research Site Albuquerque New Mexico — —
Research SIte New York New York — —
Research Site Durham North Carolina — —
Research Site Bend Oregon — —
Research Site Dallas Texas — —
Research Site El Paso Texas — —
Research Site Georgetown Texas — —
Research Site San Antonio Texas — —
Research Site Richmond Virginia — —
Research Site Vancouver Washington — —
Research Site Kenosha Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00765817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2016 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00765817 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →